XVGL

23.9040.79%

Weekly Recap | Alphabet - C +3.03%, closing in on record highs

LongbridgeAII'm LongbridgeAI. Here is the key information I extracted
- Alphabet Class C shares rose 3.03 % this week to close at 292.52 USD, outperforming the S & P 500 by approximately 0.52 percentage points amid heightened trading volume.
- Key events included the release of AlphaGenome 2, a 10.0 billion USD investment agreement in Anthropic alongside Nvidia, AI product expansions, and ongoing antitrust regulatory pressures.…
Disclaimer

The Week

Alphabet - C rose 3.03% this week to $292.52, outperforming the S&P 500 by about 0.52 percentage points. The week was choppy, with a 6.28% amplitude. The stock opened Monday around $290.55, slid to the week’s low of $283.37 on Tuesday, then climbed for three straight sessions to hit $301.62 on Thursday. It pulled back on Friday but held above $290. Average daily volume was 19.65m shares, about 17.53% above the 20-day median, with volume visibly picking up in the second half of the week.

Key Events

The week’s central thread was AI products and capital allocation. On 12 November, Google DeepMind launched AlphaGenome 2, which the company says can identify nearly twice as many DNA variants linked to disease. The same day, reports said Nvidia and Alphabet agreed to each buy $10bn of Anthropic stock at the IPO price, reinforcing capital commitments to frontier AI. On the product side, Google and Samsung began pre-orders for a range of AI smart glasses, Gemini AI landed on Apple CarPlay for hands-free use, and a faster Gemini model called Hydrogen was reported to be in internal testing. Regulatory friction also surfaced: an EU court adviser backed a $1.7bn antitrust fine, and OpenAI, Google and Anthropic were hit with a lawsuit seeking to halt frontier AI development. On the capital front, Alphabet launched roughly $3.8bn in bond offerings, with robust early demand for the Asian tranches.

Analyst Ratings

Across 62 institutions covering the stock, 43 rate it buy, 11 rate it overweight, 6 rate it hold and 2 have no opinion; none rate it underweight or sell. The consensus rating is strong buy, with a consensus target price of $393.93, about 34.67% above the last close of $292.52. Target prices range from $340 to $460, a spread of roughly $120 that points to differing views on the pace of returns from AI spending. Within the Internet Content & Information industry, Alphabet ranks 2nd out of 62 covered names.

The Week Ahead

On the macro calendar, the New York Fed manufacturing index lands on 16 November, with a prior of 25.5 and a forecast of 18. On 17 November, US retail sales, retail sales ex-autos, industrial production and the NAHB housing index are due; retail sales carry a prior of 0.8% against a 0.2% forecast, and any softness could shift risk appetite across tech. No near-term earnings are scheduled for Alphabet, with the FY2026 annual report set for 2 February 2027 after the close, carrying an estimated EPS of $19.56 and revenue of $499.7bn. Watch also for follow-through on the Anthropic investment, the EU antitrust fine and early demand signals from the AI glasses pre-orders.

In Short

Alphabet’s week ran on two tracks: a steady build-out of the AI story through AlphaGenome 2, AI glasses and the Anthropic equity stake, set against regulatory pressure from the EU fine and the frontier AI lawsuit. The price action showed fading momentum after Thursday’s surge, with visible selling near the $300 mark. The analyst set skews positive, with 54 of 62 institutions at buy or overweight and a consensus target 34.67% above spot, though the wide target range signals real disagreement on valuation. The near-term question is whether retail data shifts the macro backdrop and whether AI product delivery can keep pace with earnings expectations.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Source: Weekly Review The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.